Portefeuille d'ETF FBCG (CBOE) - Page 10 | MetaTrader

Afficher le graphique complet Full chart

Aperçu Toutes les participations Heatmap

Principaux titres en portefeuille Market Value Shares Weight %

MRNA MODERNA INC 2.433 M 55.209 K 0.044%

LGN LEGENCE CORP 2.384 M 50.819 K 0.043%

U UNITY SOFTWARE INC 2.301 M 79.066 K 0.042%

FIG FIGMA INC 2.059 M 79.419 K 0.037%

STX SEAGATE TECHNOLOGY HOLDINGS PLC 1.866 M 4 578.000 0.034%

A

ACLX ARCELLX INC 1.334 M 19.532 K 0.024%

LEGN LEGEND BIOTECH CORP 1.018 M 58.143 K 0.019%

CVS CVS HEALTH CORP 974.051 K 13.071 K 0.018%

W WAYFAIR INC 931.410 K 9 000.000 0.017%

WMT WALMART INC 878.300 K 7 372.000 0.016%

SRRK SCHOLAR ROCK HOLDING CORP 830.355 K 18.727 K 0.015%

APGE APOGEE THERAPEUTICS INC 582.580 K 8 893.000 0.011%

FLUT FLUTTER ENTERTAINMENT PLC 490.330 K 2 969.000 0.009%

ASCENDIS PHARMA A/S 400.197 K 1 770.000 0.007%

VRT VERTIV HOLDINGS CO 334.193 K 1 795.000 0.006%

Z ZILLOW GROUP INC 146.797 K 2 329.000 0.003%

1
2
3
4
5
6
7
8
9
10

Nouvelles

3 Reasons To Stick With Growth Stocks In Rotating Markets

Fidelity Blue Chip Growth Fund Q1 2026 Commentary (FBGRX)

FBCG: Bluechip Growth Investing Can Help Earn Market-Beating Returns (BATS:FBCG)

Is Your Portfolio Too Tech-Heavy?

Maintain A Growth Equity Engine In A Multi-Asset Income Strategy

CNEQ: High-Conviction Growth ETF With An Excellent Start (NYSEARCA:CNEQ)

Factor And Style Risk: Taming The Hidden Hazard To Core Equity Returns

Fidelity Blue Chip Growth ETF Q3 2025 Commentary (FBCG)

FBCG: Growth Strategy Worth Shortlisting, But Risk-Adjusted Returns Are A Problem (FBCG)

FBCG ETF: Blue-Chip Growth Allocation, Mixed Performance/Volatility Picture (BATS:FBCG)

Fidelity Blue Chip Growth ETF Q2 2025 Commentary (undefined:FBCG)

FBCG Delivers On Alpha - But Only In Bull Markets (BATS:FBCG)